Gilead Sciences Inc buy BMO Capital Markets
Start price
17.10.24
/
50%
€80.64
Target price
17.10.25
€86.86
Performance (%)
30.46%
End price
18.10.25
€105.20
Summary
This prediction ended on 18.10.25 with a price of €105.20. With a performance of 30.46% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has a follow-up prediction for Gilead Sciences Inc where he still thinks Gilead Sciences Inc is a Buy. A total of €3.10 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Gilead Sciences Inc | 0.328% | 0.328% | 20.999% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by BMO_Capital_Markets for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target raised by analysts at BMO Capital Markets from $85.00 to $94.00. They now have an "outperform" rating on the stock.
Ratings data for GILD provided by MarketBeat
In the thread Trading Gilead Sciences Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€100.00
12.02.25
12.02.25
€110.81
12.02.26
12.02.26
7.28%
09.01.26
09.01.26
Stopped prediction by BMO_Capital_Markets for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€105.20
20.10.25
20.10.25
€115.78
20.10.26
20.10.26
-0.28%
09.01.26
09.01.26
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€89.58
07.11.24
07.11.24
€94.44
07.11.25
07.11.25
15.85%
08.11.25
08.11.25
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€73.00
16.05.23
16.05.23
€91.88
16.05.24
16.05.24
-14.51%
17.05.24
17.05.24